Evidence-Based Medicine Guidelines
Risedronate for the prevention of osteoporotic fractures in postmenopausal women
Risedronate for the prevention of osteoporotic fractures in postmenopausal women is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Risedronate for the Prevention of Osteoporotic Fractures in Postmenopausal Women." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/452601/all/Risedronate_for_the_prevention_of_osteoporotic_fractures_in_postmenopausal_women.
Risedronate for the prevention of osteoporotic fractures in postmenopausal women. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/452601/all/Risedronate_for_the_prevention_of_osteoporotic_fractures_in_postmenopausal_women. Accessed March 27, 2023.
Risedronate for the prevention of osteoporotic fractures in postmenopausal women. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/452601/all/Risedronate_for_the_prevention_of_osteoporotic_fractures_in_postmenopausal_women
Risedronate for the Prevention of Osteoporotic Fractures in Postmenopausal Women [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 March 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/452601/all/Risedronate_for_the_prevention_of_osteoporotic_fractures_in_postmenopausal_women.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Risedronate for the prevention of osteoporotic fractures in postmenopausal women
ID - 452601
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/452601/all/Risedronate_for_the_prevention_of_osteoporotic_fractures_in_postmenopausal_women
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
